68
Taiwan Bio Therapeutics Co., Ltd
6892.TWO · TWO
$25.70 -1.53% (-$0.40)
1M +4.40%
Market Cap $2.45B
P/E Ratio -
Div. Yield -
ROE 42.93%
Piotroski F-Score Weak
2/9Valuation
36 /100
Fair P/B 2.72x
P/S 23.92x
EV/EBITDA N/A
Growth
50 /100
Stable Book val. growth 11.46%
Rev. growth 4.06%
FCF growth N/A
Profitability
20 /100
Weak Net margin 396.79%
Op. margin 385.07%
FCF margin 293.37%
Quality
1 /100
Poor ROE 42.93%
ROA 31.48%
Asset turnover 0.08x
Debt
66 /100
Moderate Current ratio 8.15x
Int. coverage -65.24x
Debt/Equity 0.37x
Stability
34 /100
Moderate Rev. volatility 71.54%
EPS volatility 15.13%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6892.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chun Yao Yang
Employees
20
Headquarters
Taipei City